Clinuvel Pharmaceuticals Limited - (CUVL) share price
Clinuvel Pharmaceuticals Limited - (NASDAQ:CUVL) last traded at $5.1, down 3.04% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.26B and a 52-week range of $4.81 to $8.92.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $5.1 |
| 1-day move | -3.04% |
| 52-week range | $4.81 - $8.92 |
| Market cap | $0.26B |
| From 52-week high | -42.80% |
| Volume vs average | 0.3x |
| Falling Shares risk score | 23/100 (MODERATE) |
| Country | United States |
Frequently asked questions
Why is Clinuvel Pharmaceuticals Limited - falling today?
Clinuvel Pharmaceuticals Limited - (NASDAQ:CUVL) is down 3.04% at its latest quote and trades 42.8% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Clinuvel Pharmaceuticals Limited - share price today?
Clinuvel Pharmaceuticals Limited - (NASDAQ:CUVL) last traded at $5.1, a -3.04% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Clinuvel Pharmaceuticals Limited -?
Clinuvel Pharmaceuticals Limited -'s 52-week low is $4.81 and its 52-week high is $8.92; the shares trade 42.8% below the high.
What is the market cap of Clinuvel Pharmaceuticals Limited -?
Clinuvel Pharmaceuticals Limited - has a market capitalisation of about $0.26B at the latest price.
What are the risks of investing in Clinuvel Pharmaceuticals Limited -?
Falling Shares Intelligence rates Clinuvel Pharmaceuticals Limited - 23/100 (MODERATE) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com